Jon Serbousek

Jon Serbousek is the current President and Chief Executive Officer at Orthofix. Prior to this, they were a Member Board of Directors at myoscience from September 2015 to April 2019. Jon also served as the Chairman of the Board at Vesselon from February 2015 to April 2020. Jon has been an Executive Board Member at BioCrossroads since February 2010 and will continue in this role until October 2021. Jon was previously the President US Ortho; Group President WW Ortho; and President WW Biologics at Biomet from March 2008 to September 2015. Additionally, they were the VP& GM WW Biologics; Division President Spine at Medtronic Sofamor Danek from June 2000 to February 2008. Jon is also currently a Member Board of Directors at Indiana Biosciences Research Institute, where they have served as Chairman of the Board since August 2012.

Jon Serbousek obtained a Master's degree in Bioengineering from the University of Utah, and a Bachelor of Applied Science (B.A.Sc.) in Engineering from Washington State University.

Some direct reports include James Ryaby - Chief Scientific Officer, Jill Mason - Chief Ethics and Compliance Officer, and Davide Bianchi - President, Global Orthofix Extremities.